PNC Financial Services Group
CNCE

PNC Financial Services Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

PNC Financial Services Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11
Closed – – 4149
2019
Q3 		$0 Hold
11
– – ﹤0.01% 4150
2019
Q2 		$0 Buy
+11
New +$118 ﹤0.01% 4180
2017
Q4 		– Sell
-245,337
Closed -$3.62M – 4279
2017
Q3 		$3.62M Buy
245,337
+197,565
+414% +$2.87M ﹤0.01% 823
2017
Q2 		$667K Buy
+47,772
New +$704K ﹤0.01% 1467
2016
Q3 		– Sell
-51,109
Closed -$574K – 4354
2016
Q2 		$574K Buy
51,109
+708
+1% +$9.02K ﹤0.01% 1486
2016
Q1 		$689K Buy
50,401
+24,548
+95% +$353K ﹤0.01% 1414
2015
Q4 		$491K Buy
+25,853
New +$562K ﹤0.01% 1547
2015
Q3 		– Sell
-2,000
Closed -$30K – 4729
2015
Q2 		$30K Hold
2,000
– – ﹤0.01% 3313
2015
Q1 		$30K Buy
+2,000
New +$27.9K ﹤0.01% 3313

Other funds holding CNCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

PNC Financial Services Group's CNCE Position: Q4 2019 in Review

PNC Financial Services Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2019, closing a stake of 11 shares.

PNC Financial Services Group first reported a position in CNCE in Q1 2015 and held it in 9 quarters. The position peaked at $3.62M in Q3 2017. 77 funds tracked by Wall St. Rank hold CNCE as of Q4 2019.

  • PNC Financial Services Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 11 Concert Pharmaceuticals, Inc. shares in Q4 2019.
  • PNC Financial Services Group first reported a position in Concert Pharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
  • PNC Financial Services Group's Concert Pharmaceuticals, Inc. position peaked at $3.62M in Q3 2017.
  • 77 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2019.

Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.